Brimonidine tartrate ophthalmic solution 0.025%

DRUG3 trials

Sponsors

University of Miami, Tulane University, Bausch & Lomb Incorporated

Conditions

Droopy EyelidEyelid DroopGlaucomaGlaucoma, Open-AngleGlaucoma, Primary Open AngleGlaucoma; DrugsPtosisSeasonal Allergic Conjunctivitis

Phase 3

Evaluation of Brimonidine Tartrate/Ketotifen Fumarate Combination in Adults With Seasonal Allergic Conjunctivitis

CompletedNCT05591755

Bausch & Lomb IncorporatedSeasonal Allergic Conjunctivitis

Start: 2022-11-18End: 2023-08-09Updated: 2025-07-01

Phase 4

The Effect of Lumify™ Eyedrops on Eyelid Position

CompletedNCT03782701

University of MiamiEyelid Droop

Start: 2019-06-18End: 2020-04-01Updated: 2021-06-14

The Effect of Lumify™ on Ocular Redness, Intraocular Pressure, and Eyelid Position in Glaucoma Patients

Not yet recruitingNCT04007276

Tulane UniversityDroopy Eyelid, Glaucoma, Glaucoma; Drugs +3

Start: 2026-11-10End: 2036-06-01Target: 60Updated: 2025-10-01